Exhibit 8.1
| | |
 | | mwe.com |
Via Email
Healthcare Trust of America, Inc.
16435 N. Scottsdale Road, Suite 320
Scottsdale, Arizona 85254
Re: Status as a Real Estate Investment Trust
Dear Ladies and Gentlemen:
You have requested our opinion concerning certain federal income tax considerations in connection with the exchange of outstanding 3.875% Senior Notes due 2025, 3.625% Senior Notes due 2028, 2.400% Senior Notes due 2030 and 2.050% Senior Notes due 2031 issued by Healthcare Realty Trust Incorporated (“HTA”), a Maryland corporation, for the issuance by the Healthcare Trust of America Holdings, LP (the “Issuer”), a Delaware limited partnership, of $1.150 billion aggregate principal amount of (i) 3.875% Senior Notes due 2025, (ii) 3.625% Senior Notes due 2028, (iii) 2.400% Senior Notes due 2030 and (iv) 2.050% Senior Notes due 2031 (the “Notes”), guaranteed by HTA, pursuant to a Dealer Manager Agreement, dated June 14, 2022 (the “Dealer Manager Agreement”), among you, as dealer manager (“Dealer Manager”), the Issuer and HTA. The Issuer and HTA are collectively referred to herein as the “Transaction Parties”).
The opinion set forth in this letter is based on relevant provisions of the Internal Revenue Code of 1986, as amended (the “Code”), Treasury Regulations thereunder (including proposed and temporary Treasury Regulations) (the “Regulations”) and interpretations of the foregoing as expressed in published court decisions, administrative determinations and the legislative history as of the date hereof. These provisions and interpretations are subject to change, which may or may not be retroactive in effect, that might result in modifications of our opinion.
In rendering our opinion we examined such records, certificates, documents and other materials as we considered necessary or appropriate as a basis for such opinion, including the following: (1) the registration statement on Form S-4 (the “Registration Statement”), filed by HTA with the Securities and Exchange Commission (the “Commission”) on June 14, 2022, for purposes of registering the securities of HTA and the Issuer under the Securities Act of 1933, as amended (the “Securities Act”), and the prospectus included in the Registration Statement; (2) (a) the Issuer’s and HTA’s Annual Report on Form 10-K/A for the fiscal year ended December 31, 2021, filed with the Commission on April 12, 2022 (the “2021 Annual Report on Form 10-K”), (b) the Issuer’s and HTA’s Current Reports on Form 8-K, filed with the Commission on February 28, 2022, March 1, 2022, March 14, 2022, March
| | |
 | | 415 Mission St Suite 5600 San Francisco CA 94105-2533 Tel +1 628 218 3800 Fax +1 628 877 0107 |
| US practice conducted through McDermott Will & Emery LLP. |